第32回日本乳癌学会学術総会 vs IBTR Risk Estimation

2024年7月11日(木)〜7月13日(土)に開催される第32回日本乳癌学会学術総会の抄録検索システムです。 ●アプリならではの便利機能 [開催中セッション] 会期中、その時刻に発表されているセッションが一覧表示します。 [マイスケジュール] 演題ごとにブックマークを付けると、デイリー形式のカレンダーで表示します。 [抄録文字サイズの変更] 抄録文字サイズを、大・中・小の3段階で変更することができます。 ◆◇◆　ご注意！　◆◇◆ 初回起動時にデータのダウンロードが必要です。 インターネットにつながる環境でアプリを起動後、ご利用ください。

This application is a tool to estimate the risk of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery. It provides 10-year IBTR risk estimates and treatment effects, based on clinicopathological factors (age, pathological T stage, grade, margin status, lymphovascular invasion, hormone receptor status, HER2 status) and treatment options (radiation therapy, chemotherapy, endocrine therapy, anti-HER2 therapy). The application is available for both iPhone and iPad. The tool was developed using a Cox proportional hazards model from a multicenter cohort of 8,938 patients and calibrated with treatment effects from the EBCTCG meta-analysis. It is designed for use in shared decision-making between patients and clinicians, as well as for educational purposes. The development methodology was presented at the 2025 ASCO Annual Meeting (Abstract No. 575) and published in JCO Clinical Cancer Informatics (Sagara et al., 2025). For further details, please refer to the publication. Disclaimer This application is intended for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with the treating physician. The developers assume no legal responsibility for any outcomes resulting from the use of this application.